Meanwhile, the molecular features of PD-1's other ligand, namely PD-L2, as well as its correlation with clinicopathological parameters and HCC tumor microenvironment (TME), are still poorly understood. The gene discussed is PDCD1LG2; the disease is hepatocellular carcinoma.